These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25728267)
41. Engineered disulfide crosslinking to measure conformational changes in the 26S proteasome. Reed RG; Tomko RJ Methods Enzymol; 2019; 619():145-159. PubMed ID: 30910019 [TBL] [Abstract][Full Text] [Related]
42. Maturation of the proteasome core particle induces an affinity switch that controls regulatory particle association. Wani PS; Rowland MA; Ondracek A; Deeds EJ; Roelofs J Nat Commun; 2015 Mar; 6():6384. PubMed ID: 25812915 [TBL] [Abstract][Full Text] [Related]
43. Assembly and function of the proteasome. Saeki Y; Tanaka K Methods Mol Biol; 2012; 832():315-37. PubMed ID: 22350895 [TBL] [Abstract][Full Text] [Related]
44. Regulation of murine cardiac 20S proteasomes: role of associating partners. Zong C; Gomes AV; Drews O; Li X; Young GW; Berhane B; Qiao X; French SW; Bardag-Gorce F; Ping P Circ Res; 2006 Aug; 99(4):372-80. PubMed ID: 16857963 [TBL] [Abstract][Full Text] [Related]
46. Quantifying cross-tissue diversity in proteasome complexes by mass spectrometry. Pelletier S; Schuurman KG; Berkers CR; Ovaa H; Heck AJ; Raijmakers R Mol Biosyst; 2010 Aug; 6(8):1450-3. PubMed ID: 20498902 [TBL] [Abstract][Full Text] [Related]
47. Monitoring cytoplasmic protein complexes with blue native gel electrophoresis and stable isotope labelling with amino acids in cell culture: analysis of changes in the 20S proteasome. Couttas TA; Raftery MJ; Erce MA; Wilkins MR Electrophoresis; 2011 Jul; 32(14):1819-23. PubMed ID: 21710547 [TBL] [Abstract][Full Text] [Related]
48. Discovery of a potent and highly specific β Zhou T; Cai Y; Liang L; Yang L; Xu F; Niu Y; Wang C; Zhang JL; Xu P Bioorg Med Chem Lett; 2016 Dec; 26(23):5780-5784. PubMed ID: 27816516 [TBL] [Abstract][Full Text] [Related]
49. Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development. Huber EM; Groll M Angew Chem Int Ed Engl; 2012 Aug; 51(35):8708-20. PubMed ID: 22711561 [TBL] [Abstract][Full Text] [Related]
50. Discovery of selective fragment-sized immunoproteasome inhibitors. Kollár L; Gobec M; Szilágyi B; Proj M; Knez D; Ábrányi-Balogh P; Petri L; Imre T; Bajusz D; Ferenczy GG; Gobec S; Keserű GM; Sosič I Eur J Med Chem; 2021 Jul; 219():113455. PubMed ID: 33894528 [TBL] [Abstract][Full Text] [Related]
51. Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cells. Ducoux-Petit M; Uttenweiler-Joseph S; Brichory F; Bousquet-Dubouch MP; Burlet-Schiltz O; Haeuw JF; Monsarrat B J Proteome Res; 2008 Jul; 7(7):2852-9. PubMed ID: 18510353 [TBL] [Abstract][Full Text] [Related]
52. Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits. Hovhannisyan AA; Pham TH; Bouvier D; Tan X; Touhar S; Mkryan GG; Dallakyan AM; El Amri C; Melikyan GS; Reboud-Ravaux M; Bouvier-Durand M Bioorg Med Chem Lett; 2017 Dec; 27(23):5172-5178. PubMed ID: 29113763 [TBL] [Abstract][Full Text] [Related]
53. Reduced-scale large-zone analytical gel-filtration chromatography for measurement of protein association equilibria. Beckett D Curr Protoc Protein Sci; 2001 May; Chapter 20():Unit20.5. PubMed ID: 18429160 [TBL] [Abstract][Full Text] [Related]
54. Gel-based chemical cross-linking analysis of 20S proteasome subunit-subunit interactions in breast cancer. Song H; Xiong H; Che J; Xi QS; Huang L; Xiong HH; Zhang P J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):564-570. PubMed ID: 27465334 [TBL] [Abstract][Full Text] [Related]
55. Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome. Hsu HC; Singh PK; Fan H; Wang R; Sukenick G; Nathan C; Lin G; Li H Biochemistry; 2017 Jan; 56(1):324-333. PubMed ID: 27976853 [TBL] [Abstract][Full Text] [Related]
56. N-myristoylation of the Rpt2 subunit regulates intracellular localization of the yeast 26S proteasome. Kimura A; Kato Y; Hirano H Biochemistry; 2012 Nov; 51(44):8856-66. PubMed ID: 23102099 [TBL] [Abstract][Full Text] [Related]
57. Long-range allosteric regulation of the human 26S proteasome by 20S proteasome-targeting cancer drugs. Haselbach D; Schrader J; Lambrecht F; Henneberg F; Chari A; Stark H Nat Commun; 2017 May; 8():15578. PubMed ID: 28541292 [TBL] [Abstract][Full Text] [Related]
58. Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. Xin BT; Huber EM; de Bruin G; Heinemeyer W; Maurits E; Espinal C; Du Y; Janssens M; Weyburne ES; Kisselev AF; Florea BI; Driessen C; van der Marel GA; Groll M; Overkleeft HS J Med Chem; 2019 Feb; 62(3):1626-1642. PubMed ID: 30657666 [TBL] [Abstract][Full Text] [Related]
59. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome. Nakamura Y; Umehara T; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S Biochem Biophys Res Commun; 2007 Aug; 359(3):503-9. PubMed ID: 17555716 [TBL] [Abstract][Full Text] [Related]
60. Identification of three phosphorylation sites in the alpha7 subunit of the yeast 20S proteasome in vivo using mass spectrometry. Iwafune Y; Kawasaki H; Hirano H Arch Biochem Biophys; 2004 Nov; 431(1):9-15. PubMed ID: 15464721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]